(CIDRAP News) If someone tried to kill Americans with Bacillus anthracis spores today, the nation would have a better medical tool chest for treating the sick and those potentially exposed than it had 10 years ago, when the anthrax letter attacks killed five people, but anthrax defenses are still a work in progress.
(CIDRAP News) A workshop summary released today by the Institute of Medicine (IOM) offers a wide range of observations and suggestions about what worked well and not so well during the pandemic H1N1 influenza vaccination campaigna complex, months-long operation with a cast of thousands.
(CIDRAP News) The US Centers for Disease Control and Prevention (CDC) today released new details about recommendations its vaccine advisory group made in February for Americans who receive anthrax shots.
(CIDRAP News) In the event of an influenza pandemic, medical and public health personnel and workers who make critical vaccines and drugs would have first call on scarce doses of vaccine, under the pandemic plan released by the federal government yesterday.
(CIDRAP News) – Poor policy communication and a lack of clearly defined goals seriously hindered the smallpox preparedness program that the federal government launched in 2003, according to a report released by the prestigious Institute of Medicine (IOM) last week.
(CIDRAP News) Because of the risk of heart inflammation, the Advisory Committee on Immunization Practices (ACIP) recommended yesterday that the federal smallpox immunization program not expand now beyond smallpox response teams to the larger population of health workers and emergency responders.
(CIDRAP News) Federal agencies have reported four more cases of heart inflammation in military personnel who received smallpox shots, including one severe case. The report came as officials advised the states to suspend smallpox shots for people with three or more major cardiac risk factors as well as for those with known heart disease.
(CIDRAP News) The Institute of Medicine (IOM) has urged the federal government to move slowly and carefully on its pre-event smallpox vaccination program, with a pause after the initial phase to assess the vaccine's safety before moving to a broader inoculation campaign.